Just read the article and honestly, much worse than I assumed. It’s true that many running fans in the US don’t pay attention to Kenyan distance runners who aren’t in your face successful, but in our sport, a 10k ncaa champ is a known quantity. Comparing that to Ches is just silly. There are athletes who have represented their country on an international level multiple times who are less known than many ncaa 10k champs.
The tone of the article is accusatory and barely masks it. The first half of the article both dilutes her success by omitting key aspects of her career and focuses on her NOT being tested by a specific organization (who it later says did test her). It’s only later we learn that she HAS been tested twice by USADA in 2022 (a point the article implies is suspiciously low by comparing it to two high profile Americans, people USADA the paragraph above says is their focus) and that she may have also been tested when in Kenya, a place she was in for only a few months before NYCM.
If the point of the article was to spotlight the gaps in testing for international athletes training in the US, it did a poor job. Lokedi clearly had an outstanding performance, doesn’t mean she dopes. The whole structure of the article is needlessly crude.